AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitaglyn M 50/500 Tablet PR

Prescription Icon
Prescription Required

Marketer

Zydus Healthcare Limited

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitaglyn M 50/500 Tablet PR

Diabetic patients with type 2 mellitus may find relief from elevated blood glucose levels with Sitaglyn M 50/500 PR tablets, a dual-action medication. This formulation helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. Sitaglyn M 50/500 PR can be used independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is tailored to individual health status, glycemic control, and concurrent medications. Consuming the medication with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Maintaining the prescribed diet and exercise regimen is crucial for diabetes management. Common adverse effects include nausea, vomiting, diarrhea, abdominal distress, headache, and pharyngitis. Hypoglycemia is a potential risk, especially when combined with insulin or sulfonylureas; prompt identification and management of low blood sugar is essential. This medication isn't universally suitable. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic disorders, or excessive alcohol consumption. Pregnant or lactating individuals should seek medical advice before use. Interaction with other drugs is possible; complete disclosure of all medications to your doctor is vital for safety. Alcohol should be avoided due to its potential to decrease blood glucose. Kidney function and blood sugar monitoring will be conducted before, during, and after treatment.

Primary Ingredients of Sitaglyn M 50/500 Tablet PR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Sitaglyn M 50/500 Tablet PR

Managing Type 2 Diabetes

Major Benefits of Sitaglyn M 50/500 Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Take Sitaglyn M 50/500 Tablet PR with a meal.

Common Side effects of Sitaglyn M 50/500 Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglyn M 50/500 Tablet PR:

Follow your physician's instructions or consult the product label for dosage guidance. Administer Sitaglyn M 50/500 Tablet PR with a meal.

How Sitaglyn M 50/500 Tablet PR works:

Sitaglyn M 50/500 tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves the body's insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and augmenting insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaglyn M 50/500 Tablet PR with alcohol is not advised due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitaglyn M 50/500 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential benefits against the risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitaglyn M 50/500 Tablet PR while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaglyn M 50/500 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Sitaglyn M 50/500 Tablet PR is contraindicated in those with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Sitaglyn M 50/500 Tablet PR, as its use may be unsafe. A physician's consultation is recommended.

What if you forget to take Sitaglyn M 50/500 Tablet PR :

Should you forget a dose of Sitaglyn M 50/500 Tablet PR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaglyn M 50/500 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitaglyn M 50/500 Tablet PR

Sitaglyn M 50/500 Tablet PR combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sitaglyn M 50/500 Tablet PR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitaglyn M 50/500 Tablet PR may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Sitaglyn M 50/500 Tablet PR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglyn M 50/500 Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitagliptin/Metformin (Sitaglyn M 50/500 Tablet PR) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect necessitates avoiding this medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Sitaglyn M 50/500 Tablet PR combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaglyn M 50/500 Tablet PR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaglyn M 50/500 Tablet PR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglyn M 50/500 Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitaglyn M 50/500 Tablet PR) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitaglyn M 50/500 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaglyn M 50/500 Tablet PR combines sitagliptin and metformin to manage type 2 diabetes in adults. It helps control blood sugar levels when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaglyn M 50/500 Tablet PR commonly causes hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitaglyn M 50/500 Tablet PR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Sitaglyn M 50/500 Tablet PR is unsafe due to an increased risk of lactic acidosis.
Sitagliptin/Metformin (Sitaglyn M 50/500 Tablet PR) can cause lactic acidosis, a serious, potentially life-threatening condition characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek urgent medical attention.
Prolonged use of Sitaglyn M 50/500 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitaglyn M 50/500 Tablet ...
131